First malaria vaccine slashes deaths among young children in Africa

First malaria vaccine slashes deaths among young children in Africa
Pixabay

The first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, reports Science:

a pilot rollout of the vaccine, called RTS,S or Mosquirix and made by GlaxoSmithKline, also showed a 22% reduction in severe malaria in kids young enough to receive a three-shot series. Hundreds of thousands of children are born annually in the parts of Ghana, Kenya, and Malawi included in the analysis.

“The RTS,S malaria vaccine is already saving lives,” said John Tanko Bawa, director of malaria vaccine implementation at PATH, a nonprofit that develops vaccines and therapies for global health problems. He added, “What we have seen is a considerable impact of a vaccine described as having modest efficacy.” (A late-stage clinical trial delivered lackluster results on the durability of the vaccine’s protection.)

The 13% drop in deaths is so remarkable that “I was surprised I didn’t hear any gasps when it was stated,” joked medical epidemiologist Mary Hamel, who led the WHO pilot program. The mortality decline could translate to tens of thousands of lives saved if RTS,S, which WHO approved for widespread use in 2021, is more broadly deployed: In 2021, malaria killed an estimated 468,000 children under age 5 in sub-Saharan Africa. Seventeen countries in the region have already won approval to receive doses that will start to roll out next year.

“The data speak for themselves,” said Kwaku Poku Asante, a physician and epidemiologist who directs the Kintampo Health Research Centre and who oversaw the analysis in Ghana. “This was a very large, very robust evaluation done in a real-life setting, and you’re seeing this huge impact.”

In clinical trial results published in 2015, RTS,S showed 36.3% efficacy against clinical malaria a median of 4 years after toddlers were vaccinated. In the $70 million pilot, mandated by WHO and launched in 2019, nearly 2 million very young children have been vaccinated in the three countries.

In other news, British doctors say a new course of treatment for cervical cancer could cut cervical cancer deaths by 35%.

A new blood test can screen for 50 different cancers.

Doctors recently used a surgical robot to carry out incredibly complicated spinal surgery, and used a robot to do a liver transplant. Robots can fit in small spaces in people’s bodies that a surgeon can’t reach without cutting through living tissue.

Scientists recently came up with an “inverse vaccine” that has shown it can treat auto-immune diseases in a lab setting, so doctors might be able to use it to reverse multiple sclerosis. Note, however, that the FDA can take many years to approve life-saving drugs and medical devices.

90% of those with cystic fibrosis will get a new lease on life with a new breakthrough drug, assuming the FDA doesn’t block it.

A new ultrasound therapy could help treat cancer and Alzheimer’s disease and skull implants could fight depression.

Artificial wombs could be coming soon, to prevent premature babies from dying or being permanently disabled due to premature life outside the womb. Doctors are already beginning to do womb transplants. A woman who was previously unable to have children recently received her sister’s womb in the first womb transplant in the United Kingdom.

Artificial intelligence is now developing highly-effective antibodies to fight disease. Doctors overseas are using artificial intelligence to detect cases of breast cancer more effectively.

Scientists recently developed a treatment for alcoholism that reduces drinking by 90% among lab monkeys.

LU Staff

LU Staff

Promoting and defending liberty, as defined by the nation’s founders, requires both facts and philosophical thought, transcending all elements of our culture, from partisan politics to social issues, the workings of government, and entertainment and off-duty interests. Liberty Unyielding is committed to bringing together voices that will fuel the flame of liberty, with a dialogue that is lively and informative.

Comments

For your convenience, you may leave commments below using Disqus. If Disqus is not appearing for you, please disable AdBlock to leave a comment.